EX-4.2





 Exhibit 4.2 

APPLOVIN CORPORATION 

INVESTORS’ RIGHTS AGREEMENT 

This Investors’ Rights Agreement (this “Agreement”) is made and entered into as of August 15, 2018 by and
among Applovin Corporation, a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor,” each
of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder,” and any holder of a Lender Warrant that becomes a party to this Agreement in accordance with Section 7.14
hereof. 
 RECITALS 

WHEREAS, the Company and certain of the Investors are parties to that certain Series A Preferred Stock Purchase Agreement dated as of
July 13, 2018 by and among the Company and such Investors, as amended from time to time (the “Purchase Agreement”); and 

WHEREAS, in order to induce the Company to enter into the Purchase Agreement and to induce the Investors to invest funds in the Company
pursuant to the Purchase Agreement, the Investors and the Company hereby agree that this Agreement shall govern the rights of the Investors to cause the Company to register shares of Common Stock issuable to the Investors, to receive certain
information from the Company, and to participate in future equity offerings by the Company, and shall govern certain other matters as set forth in this Agreement; 

NOW, THEREFORE, in consideration of the foregoing recitals and the mutual promises hereinafter set forth, the parties hereto hereby agree as
follows: 
 1. DEFINITIONS. For purposes of this Agreement: 

“Adjusted EBITDA” means net income (loss) adjusted to exclude stock-based compensation expense, depreciation and
amortization expense, interest and other expense, net, provision (benefit) for income taxes, and restructuring charges and one-time nonrecurring charges and one-time
nonrecurring gain (in each case, as determined in accordance with GAAP). 
 “Affiliate” means, (i) with respect
to any specified Person, any other Person who or which, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member or partner, officer or
director of such Person or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management company with, such Person and (ii) with respect to Hontai,
with the prior written consent of the Company, such consent not to be unreasonably withheld, up to 5 limited partners of Hontai GP or Affiliates of Hontai GP. For purposes of this definition, the terms “controlling,”
“controlled by,” or “under common control with” shall mean the possession, directly or indirectly, of (a) the power to direct or cause the direction of the management
and policies of a Person, whether through the ownership of voting securities, by contract, or otherwise, or (b) the power to elect or appoint at least 50% of the directors, managers, general partners, or persons exercising similar authority
with respect to such Person. 












 “Anti-Bribery Laws” means anti-bribery and anti-corruption laws,
regulations or ordinances applicable to the Company and its Subsidiaries and their respective operations from time to time, including without limitation (i) the U.S. Foreign Corrupt Practices Act of 1977 (as amended), (ii) the United Kingdom
Bribery Act, (iii) anti-bribery legislation promulgated by the European Union and implemented by its member states, and (iv) legislation adopted in furtherance of the OECD Convention on Combating Bribery of Foreign Public Officials in
International Business Transactions. 
 “Anti-Money Laundering Laws” means anti- money laundering-related laws,
regulations, and codes of practice applicable to the Company and its Subsidiaries and their respective operations from time to time, including without limitation (i) the EU Anti-Money Laundering Directives and any laws, decrees, administrative
orders, circulars, or instructions implementing or interpreting the same, and (ii) the applicable financial recordkeeping and reporting requirements of the U.S. Currency and Foreign Transaction Reporting Act of 1970, as amended. 

“Automatic Shelf Registration Statement” shall have the meaning given to that term in SEC Rule 405. 

“business day” means a weekday on which banks are open for general banking business in San Francisco, California. 

“Class A Common Stock” means shares of the Company’s Class A Common Stock,
par value $0.0001 per share. 
 “Class F Common Stock” means shares of the
Company’s Class F Common Stock, par value $0.0001 per share. 
 “Closing Anniversary” means the one
(1) year anniversary of the Closing (as defined in the Purchase Agreement). 
 “Code” means the Internal
Revenue Code of 1986, as amended. 
 “Common Stock” means shares of the Class A Common Stock and
Class F Common Stock. 
 “Constructive Sale” shall mean, with respect to any security, a short sale with
respect to such security, entering into or acquiring an offsetting derivative contract with respect to such security, entering into or acquiring a futures or forward contract to deliver such security, or entering into any other hedging or other
derivative transaction that has the effect of materially changing the economic benefits and risks of ownership. 

“Damages” means any loss, damage, or liability (joint or several) to which a party hereto may become subject under the
Securities Act, the Exchange Act, or other federal or state law, insofar as such loss, damage, or liability (or any action in respect thereof) arises out of or is based upon (a) any untrue statement or alleged untrue statement of a material
fact contained in any registration statement of the Company, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, and any free-writing prospectus and any issuer information (as defined
in Rule 433 of the Securities Act) filed or 

  
 2 













 required to be filed pursuant to Rule 433(d) under the Securities Act or any other document incident to such
registration prepared by or on behalf of the Company or used or referred to by the Company; (b) an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not
misleading; or (c) any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities
Act, the Exchange Act, or any state securities law. 
 “Demand Notice” means notice sent by the Company to the
Holders specifying that a demand registration has been requested as provided in Section 3.1.1. 
 “Derivative
Securities” means any securities or rights convertible into, or exercisable or exchangeable for (in each case, directly or indirectly), Common Stock, including options and warrants. 

“Deemed Liquidation Event” has the meaning set forth for such term in the certificate of incorporation of the Company
most recently filed with the Delaware Secretary of State that contains such a definition, whether or not the holders of outstanding shares of Preferred Stock elect otherwise by written notice sent to the Company as provided in such definition. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder. 
 “Excluded Registration” means (a) a registration relating to the sale of securities to employees
of the Company or a subsidiary pursuant to an equity incentive, stock option, stock purchase, or similar plan; (b) a registration relating to an SEC Rule 145 transaction; (c) a registration on any form that does not include substantially
the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or (d) a registration in which the only Common Stock being registered is Common Stock issuable upon conversion
of debt securities that are also being registered. 
 “Export Control Laws” means the EC Regulation 428/2009 and the
implementing laws and regulations of the EU member states; the U.S. Export Administration Act, U.S. Export Administration Regulations, U.S. Arms Export Control Act, U.S. International Traffic in Arms Regulations, and their respective implementing
rules and regulations; the U.K. Export Control Act 2002 (as amended and extended by the Export Control Order 2008) and its implementing rules and regulations; and other similar export control laws or restrictions applicable to the Company and its
Subsidiaries and their respective operations from time to time. 
 “Form
S-1” means such form under the Securities Act as in effect on the date hereof or any successor registration form under the Securities Act subsequently adopted by the SEC. 

“Form S-3” means such form under the Securities Act as in effect on the date
hereof or any registration form under the Securities Act subsequently adopted by the SEC that permits incorporation of substantial information by reference to other documents filed by the Company with the SEC. 

“Founders” means Adam Foroughi, Andrew Karam and John Krystynak. 

  
 3 













 “Free Writing Prospectus” means a free-writing prospectus, as
defined in Rule 405 under the Securities Act. 
 “Fully Exercising Investor” shall have the meaning set forth in
Section 4.2. 
 “Fundamental Event” means either (a) Adam Foroughi ceasing to serve as the Company’s
Chief Executive Officer for any reason other than a transition to a Chief Operating Officer or similar role at the Company in connection with an IPO or (b) at any time after the Closing Anniversary, the Company’s aggregate Adjusted EBITDA
for the four (4) most recently completed fiscal quarters being less than the applicable Requisite EBITDA. 

“GAAP” means generally accepted accounting principles in the United States. 

“Gaming Subsidiaries” has the meaning given to such term in the Purchase Agreement. 

“Holder” means any holder of Registrable Securities who is a party to this Agreement. 

“Hontai” means AppLovin Holdings LLC. 

“Hontai GP” means any of Orient Hontai Capital Investment (Chengdu) Co., Ltd.
(东方泓泰资本投资(成都)有限公司), a PRC corporation, and its stockholders. 

“Immediate Family Member” means a child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law,
son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, of a natural person referred to herein. 

“Initiating Holders” means, collectively, Holders who properly initiate a registration request under this Agreement.

 “Investor Notice” shall have the meaning set forth in Section 4.2. 

“IPO” means the Company’s first underwritten public offering of its Common Stock under the Securities Act. 

“Key Holder Registrable Securities” means (a) the shares of Common Stock held by the Key Holders, and
(b) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of such shares. 

“KKR” means the KKR Investor and its Affiliates. 

“KKR Investor” means KKR Denali Holdings, L.P. 

“KKR Designee” has the meaning set forth in the Voting Agreement. 

“Lender Registrable Securities” means (a) the Common Stock issuable or issued upon the exercise of any Lender
Warrant and (b) the Common Stock issuable or issued upon conversion of the Preferred Stock issuable or issued pursuant to the exercise of any Lender Warrant; provided, however, that before the holder of any Lender
Warrant shall be entitled to 

  
 4 













 exercise any rights under this Agreement, such holder must either (i) become a party to this Agreement
as a “Lender” or (ii) agree to be bound by the terms of this Agreement related to registration rights applicable to the Lender Registrable Securities in a separate written agreement between such holder and the Company (including,
without limitation, in a Lender Warrant). 
 “Lender Warrant” means any warrant to purchase shares of capital stock
of the Company issued to banks, equipment lessors or other financial institutions pursuant to a debt financing or equipment leasing transaction where the Company’s Board of Directors (the “Board”) has approved the grant
to the holder thereof of “piggyback” registration rights. 
 “Major Investor” means any Investor that,
individually or together with such Investor’s Affiliates, holds at least 18,181,818 shares of Registrable Securities (as adjusted for any stock split, stock dividend, combination, recapitalization, reclassification or the like effected after
the date hereof); provided, however, that Hontai shall be considered a “Major Investor” so long as it, individually or together with its Affiliates, holds at least 8,698,137 shares of Registrable Securities (as
adjusted for any stock split, stock dividend, combination, recapitalization, reclassification or the like effected after the date hereof). 

“New Securities” means, collectively, equity securities of the Company, whether or not currently authorized,
Derivative Securities and any rights, options, or warrants to purchase such equity securities, or securities of any type whatsoever that are, or may become, convertible or exchangeable into or exercisable for (in each case, directly or indirectly)
such equity securities; provided however, that “New Securities shall exclude: (a) Exempted Securities (as defined in the Restated Certificate); and (b) shares of Common Stock issued in the IPO. 

“Offer Notice” shall have the meaning set forth in Section 4.1. 

“Person” means any individual, corporation, partnership, trust, limited liability company, association or other
entity. 
 “Preferred Stock” means shares of the Company’s Series A Preferred Stock. 

“Privacy Legal Requirements” has the meaning given to such term in the Purchase Agreement. 

“Pro Rata Amount” means, for each Major Investor, that portion of the New Securities identified in an Offer Notice
which equals the proportion that the Common Stock issued and held, or issuable (directly or indirectly) upon the conversion and/or exercise, as applicable, of the Preferred Stock and any other Derivative Securities then held by such Major Investor
bears to the total Common Stock of the Company then outstanding (assuming the conversion and/or exercise, as applicable of all shares of Preferred Stock and other Derivative Securities then outstanding). 

“Registrable Securities” means (a) Common Stock issued or issuable upon conversion of the Preferred Stock;
(b) any Common Stock, or any Common Stock issued or issuable upon conversion of other Derivative Securities, held by an Investor (or its Affiliates); (c) the Key Holder Registrable Securities, provided, however, that
such Key Holder Registrable Securities shall not be deemed Registrable Securities and the Key Holders shall not be deemed Holders for the purposes of Sections 2.1, 2.2, 3.10 and 4; (d) the Lender Registrable Securities, provided, 

  
 5 













 however, that such Lender Registrable Securities shall not be deemed Registrable Securities
and the Lenders shall not be deemed Holders for the purposes of Sections 2.1, 2.2, 3.1, 3.10, 4 and 7.6; and (e) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is
issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares referenced in clauses (a) through (d) above; excluding in all cases, however, any Registrable Securities sold by a Person in a
transaction in which the applicable rights under this Agreement are not assigned pursuant to Section 7.1, and excluding for purposes of Section 3 any shares for which registration rights have terminated pursuant to Section 6.2 of this
Agreement. Notwithstanding the foregoing, the Company shall in no event be obligated to register any Preferred Stock of the Company, and Holders of Registrable Securities will not be required to convert their Preferred Stock into Common Stock in
order to exercise the registration rights granted hereunder, until immediately before (and subject to the consummation of) the closing of the offering to which the registration relates. 

“Registrable Securities then outstanding” means the number of shares determined by adding the number of shares of
outstanding Common Stock that are Registrable Securities and the number of shares of Common Stock issuable (directly or indirectly) pursuant to then exercisable and/or convertible securities that are Registrable Securities. 

“Requisite EBITDA” means (a) Adjusted EBITDA for the last four (4) completed fiscal quarter period ending
prior to the Closing Anniversary, of $200,000,000 and (b) for each subsequent fiscal quarter, an Adjusted EBITDA equal to the Requisite EBITDA for the immediately prior four (4) completed fiscal quarter period multiplied by 104.6%.

 “Restated Certificate” means the Company’s Restated Certificate of Incorporation (as may be amended from
time to time in accordance with the provisions set forth therein). 
 “ Restricted Securities” means the securities
of the Company required to bear the legend set forth in Section 3.12.2 hereof. 
 “Sanctioned Person” means a
Person that is (a) the subject of Sanctions, (b) located in or organized under the laws of a country or territory which is the subject of country- or territory-wide Sanctions (including without limitation Cuba, Iran, North Korea, Syria, or
the Crimea region), or (c) majority-owned or controlled by any of the foregoing. 
 “Sanctions” means those
trade, economic and financial sanctions laws, regulations, embargoes, and restrictive measures (in each case having the force of law) administered, enacted or enforced from time to time by (i) the United States (including without limitation the
Department of Treasury, Office of Foreign Assets Control), (ii) the European Union and enforced by its member states, (iii) the United Nations, (iv) Her Majesty’s Treasury, or (v) other similar governmental bodies with regulatory
authority over the Company and its Subsidiaries and their respective operations from time to time. 
 “SEC” means
the Securities and Exchange Commission. 
 “SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities
Act. 
 “SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities Act. 

  
 6 













 “SEC Rule 405” means Rule 405 promulgated by the SEC under the
Securities Act. 
 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder. 
 “Selling Expenses” means all underwriting discounts, selling commissions, and stock
transfer taxes applicable to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by the Company as provided in Section 3.6.

 “Selling Holder Counsel” means one counsel for the selling Holders. 

“Series A Preferred Stock” means shares of the Company’s Series A Preferred Stock, par value $0.0001 per share.

 “Standoff Period” means the period commencing on the date of the final prospectus relating to an underwritten
public offering of the Company’s Common Stock under the Securities Act and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days). 

“Stock Sale” has the meaning given to such term in the Voting Agreement as of the date hereof. 

“ Transfer” means, with respect to any security, the direct or indirect assignment, sale, transfer, tender, pledge,
hypothecation, or the grant, creation or suffrage of a lien or encumbrance in or upon, or the gift, placement in trust, or the Constructive Sale or other disposition of such security (including transfer by testamentary or intestate succession,
merger or otherwise by operation of law) or any right, title or interest therein (including, but not limited to, any right or power to vote to which the holder thereof may be entitled, whether such right or power is granted by proxy or otherwise),
or the record or beneficial ownership thereof, the offer to make such a sale, transfer, Constructive Sale or other disposition, and each agreement, arrangement or understanding, whether or not in writing, to effect any of the foregoing. 

“Voting Agreement” means that certain Voting Agreement dated of even date hereof by and among the Company and the
Investors. 
 2. INFORMATION RIGHTS. 

2.1 Delivery of Financial Statements. 

2.1.1 Information to be Delivered. The Company shall deliver the following to each Major Investor, provided that the
Board has not reasonably determined that such Major Investor is a competitor of the Company (it being understood that neither the KKR Investor nor any of its affiliated investment funds shall be deemed to be a competitor of the Company): 

(a) As soon as practicable, but in any event within one-hundred and eighty calendar (180) after
the end of each fiscal year of the Company, the Company shall deliver, (i) a balance sheet as of the end of such year, (ii) statements of income and of cash flows for such year, and (iii) a statement of stockholders’ equity as of
the end of such year, all of which shall be audited and certified by independent public accountants of nationally recognized standing selected by the Company. 

  
 7 













 (b) As soon as practicable, but in any event within forty-five (45) calendar days after the
end of each of the first three (3) quarters of each fiscal year of the Company, the Company shall deliver unaudited statements of income and of cash flows for such fiscal quarter, and an unaudited balance sheet and a statement of
stockholders’ equity as of the end of such fiscal quarter, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments and
(ii) not contain all notes thereto that may be required in accordance with GAAP). 
 (c) As soon as practicable, but in any event
within thirty (30) calendar days of the end of each month, the Company shall deliver an unaudited income statement and statement of cash flows for such month, and an unaudited balance sheet and statement of stockholders’ equity as of the
end of such month, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments and (ii) not contain all notes thereto that may
be required in accordance with GAAP). 
 (d) Consolidation. If, for any period, the Company has any subsidiary whose accounts are
consolidated with those of the Company, then in respect of such period the financial statements delivered pursuant to Section 2.1.1 shall be the consolidated and consolidating financial statements of the Company and all such consolidated
subsidiaries. 
 2.2 Inspection. The Company shall permit each Major Investor, at such Major
Investor’s expense, and on such Major Investor’s written request, to visit and inspect the Company’s properties; examine its books of account and records; and discuss the Company’s affairs, finances, and accounts with its
officers, during normal business hours of the Company as may be reasonably requested by the Major Investor; provided, however, that the Company shall not be obligated pursuant to this Section 2.2 to provide
access to any information that it reasonably and in good faith considers to be confidential information (unless covered by an enforceable confidentiality agreement, in form reasonably acceptable to the Company), a trade secret or the disclosure of
which would adversely affect the attorney-client privilege between the Company and its counsel. 
 2.3 Observer
Rights. As long as the KKR Investor or any of its Affiliates is a Major Investor, the Company shall invite a representative of KKR to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall
give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust, to act in
a fiduciary manner and to be subject to the same confidentiality provisions as KKR with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such
representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a
conflict of interest. 

  
 8 













 2.4 Confidentiality. Each Investor agrees that such Investor
will keep confidential and will not disclose, divulge, or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Section 2 unless
such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Section 2.3 by such Investor), (b) is or has been independently developed or conceived by the Investor without
use of the Company’s confidential information, or (c) is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of confidentiality such third party may have to the Company;
provided, however, that an Investor may disclose confidential information (i) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection
with monitoring its investment in the Company; (ii) to any existing Affiliate, partner, limited partner, member, direct or indirect equity holder, or wholly owned subsidiary of such Investor in the ordinary course of business, but only if such
Investor informs such Person that such information is confidential and directs such Person to maintain the confidentiality of such information; or (iii) as may otherwise be required by law if the Investor promptly notifies the Company of such
disclosure and takes reasonable steps to minimize the extent of any such required disclosure (any Person permitted to receive confidential information pursuant to clauses (i)-(iii) above, a “Permitted Disclosee”).
Furthermore, (x) nothing contained herein shall prevent any Investor or any Permitted Disclosee from entering into any business, entering into any agreement with a third party, or investing in or engaging in investment discussions with any
other company (whether or not competitive with the Company), provided that such Investor or Permitted Disclosee does not, except as permitted in accordance with this Section 2.4, disclose or otherwise make use of any proprietary or confidential
information of the Company in connection with such activities and (y) notwithstanding any provision herein to the contrary, the receipt of confidential information regarding the Company or any other third party by any Investor (or any of its
representatives), including as a result of serving on the Board or attending any Board meetings or other meetings of the Company as a Board observer, shall not be deemed to impute such confidential information to any of such Investor’s
Affiliates, including its affiliated investment funds (or their representatives), absent an affirmative act of disclosure by such Investor (or its representatives) to such affiliated investment fund (or its representatives). 

3. REGISTRATION RIGHTS. 

3.1 Demand Registration. 

3.1.1 Form S-1 Demand. If at any time after the earlier of (a) four (4) years after the
date of this Agreement or (b) one hundred eighty (180) days after the effective date of the registration statement for the IPO, the Company receives a request from any Key Holder or KKR that the Company file a Form S-1 registration statement with respect to any Registrable Securities then outstanding (and the Registrable Securities subject to such request have an anticipated aggregate offering price, net of Selling Expenses,
of at least $50,000,000), then the Company shall (i) within ten (10) days after the date such request is given, give a Demand Notice to all Holders other than the Initiating Holders; and (ii) use commercially reasonable efforts
to as soon as practicable, and in any event within ninety (90) days after the date such request is given by the Initiating Holders, file a Form S-1 registration statement under the Securities Act covering
all Registrable Securities that the Initiating Holders requested to be 

  
 9 













 
registered and any additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within
twenty (20) days after the date the Demand Notice is given, and in each case, subject to the limitations of Section 3.1.3 and Section 3.3. 

3.1.2 Form S-3 Demand. If at any time when it is eligible to use a Form S-3 registration statement, the Company receives a request from any Key Holder or KKR that the Company file a Form S-3 registration statement with respect to outstanding
Registrable Securities of such Holders having an anticipated aggregate offering price, net of Selling Expenses, of at least $10,000,000, then the Company shall (a) within ten (10) days after the date such request is given, give a Demand
Notice to all Holders other than the Initiating Holders; and (b) use commercially reasonable efforts to as soon as practicable, and in any event within forty-five (45) days after the date such request is given by the Initiating Holders, file a
Form S-3 registration statement under the Securities Act covering all Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder
to the Company within twenty (20) days of the date the Demand Notice is given, and in each case, subject to the limitations of Section 3.1.3 and Section 3.3. 

3.1.3 Delay. Notwithstanding the foregoing obligations, if the Company furnishes to Holders requesting a registration pursuant to this
Section 3.1 a certificate signed by the Company’s chief executive officer stating that in the good faith judgment of the Board it would be materially detrimental to the Company and its stockholders for such registration statement to either
become effective or remain effective for as long as such registration statement otherwise would be required to remain effective, because such action would (a) materially interfere with a significant acquisition, corporate reorganization, or
other similar transaction involving the Company; (b) require premature disclosure of material information that the Company has a bona fide business purpose for preserving as confidential; or (c) render the Company unable to comply with
requirements under the Securities Act or Exchange Act, then the Company shall have the right to defer taking action with respect to such filing, and any time periods with respect to filing or effectiveness thereof shall be tolled correspondingly,
for a period of not more than ninety (90) days after the request of the Initiating Holders is given; provided, however, that, (i) the Company may not invoke this right more than once in any twelve
(12) month period and (ii) the Company shall not register any securities for its own account or that of any other stockholder during such ninety (90) day period other than an Excluded Registration. 

3.1.4 Limitations. The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to
Section 3.1.1: (a) during the period that is sixty (60) days before the Company’s good faith estimate of the date of filing of, and ending on a date that is one hundred eighty (180) days after the effective date of, a
Company-initiated registration, provided, that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective; (b) after the Company has effected two
(2) registrations pursuant to Section 3.1.1; or (c) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on Form S- 3 pursuant to a
request made pursuant to Section 3.1.2. The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Section 3.1.2: (i) during the period that is thirty (30) days before the
Company’s good faith estimate of the date of filing of, and ending on a date that is ninety (90) days after the effective 

  
 10 













 
date of, a Company-initiated registration, provided, that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective;
or (ii) if the Company has effected two (2) registrations pursuant to Section 3.1.2 within the twelve (12) month period immediately preceding the date of such request (provided, that if at any time the Company is eligible to file
an Automatic Shelf Registration Statement and the Company does not have an effective Automatic Shelf Registration Statement for the benefit of the KKR Investor, this clause (ii) shall not limit the rights of the KKR Investor to demand the
filing of an Automatic Shelf Registration Statement and to be deemed the Initiating Holder for purposes of such Automatic Shelf Registration Statement). A registration shall not be counted as “effected” for purposes of this
Section 3.1.4 until such time as the applicable registration statement has been declared effective by the SEC. 
 3.2
Company Registration. If the Company proposes to register (including, for this purpose, a registration effected by the Company for stockholders other than the Holders) any of its Common Stock under the Securities Act
in connection with the public offering of such securities solely for cash (other than in an Excluded Registration), the Company shall, at such time, promptly give each Holder notice of such registration. Upon the request of each Holder given within
twenty (20) days after such notice is given by the Company, the Company shall, subject to the provisions of Section 3.3, cause to be registered all of the Registrable Securities that each such Holder has requested to be included in such
registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 3.2 before the effective date of such registration, whether or not any Holder has elected to include Registrable
Securities in such registration. The expenses (other than Selling Expenses) of such withdrawn registration shall be borne by the Company in accordance with Section 3.6. 

3.3 Underwriting Requirements. 

3.3.1 Inclusion. If, pursuant to Section 3.1, the Initiating Holders intend to distribute the Registrable Securities covered by
their request by means of one or more underwritings, they shall so advise the Company as a part of their request made pursuant to Section 3.1, and the Company shall include such information in the Demand Notice. The underwriter(s) will be
selected by the Company, subject only to the reasonable approval of the holders of a majority of Registrable Securities held by the Initiating Holders. In such event, the right of any Holder to include such Holder’s Registrable Securities in
such registration shall be conditioned upon such Holder’s participation in such underwriting. All Holders proposing to distribute their securities through such underwriting shall (together with the Company as provided in Section 3.4(e))
enter into an underwriting agreement in customary form with the underwriter(s) selected for such underwriting. Notwithstanding any other provision of this Section 3.3, if the managing underwriter(s) advise(s) the Initiating Holders in writing
that marketing factors require a limitation on the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities that otherwise would be underwritten pursuant hereto, and the number of
Registrable Securities that may be included in the underwriting shall be allocated among such Holders of Registrable Securities, including the Initiating Holders, in proportion (as nearly as practicable) to the number of Registrable Securities owned
or held by each Holder or in such other proportion as shall mutually be agreed to by all such selling Holders; provided, however, that the number of Registrable Securities owned or held by the Holders to be included in
such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the
number of shares allocated to any Holder to the nearest one hundred (100) shares. 

  
 11 













 3.3.2 Underwriter Cutback. In connection with any offering involving an underwriting
of shares of the Company’s capital stock pursuant to Section 3.2, the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the Holders accept the terms of the underwriting as
agreed upon between the Company and its underwriters. If the total number of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds the number of securities to be sold (other than by the
Company) that the underwriters in their reasonable discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable
Securities, which the underwriters and the Company in their sole discretion determine will not jeopardize the success of the offering. If the underwriters determine that less than all of the Registrable Securities requested to be registered can be
included in such offering, then the Registrable Securities that are included in such offering shall be allocated among the selling Holders in proportion (as nearly as practicable to) the number of Registrable Securities owned or held by each selling
Holder or in such other proportions as shall mutually be agreed to by all such selling Holders. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares allocated
to any Holder to the nearest one hundred (100) shares. Notwithstanding the foregoing, in no event shall (a) the number of Registrable Securities included in the offering be reduced unless all other securities (other than securities to be
sold by the Company) are first entirely excluded from the offering or (b) the number of Registrable Securities included in the offering be reduced below 30% of the total number of securities included in such offering, unless such offering is
the IPO, in which case the selling Holders may be excluded further if the underwriters make the determination described above and no other stockholder’s securities are included in such offering. For purposes of the provision in this
Section 3.3.2 concerning apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the partners, members, retired partners, retired members, stockholders, and Affiliates of such Holder, or the
estates and Immediate Family Members of any such partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing Persons, shall be deemed to be a single “selling Holder,” and any pro rata
reduction with respect to such “selling Holder” shall be based upon the aggregate number of Registrable Securities owned or held by all Persons included in such “selling Holder,” as defined in this sentence. 

3.3.3 Registration Not Effected. For purposes of Section 3.1, a registration shall not be counted as “effected” if, as a
result of an exercise of the underwriter’s cutback provisions in Section 3.3.1, fewer than fifty percent (50%) of the total number of Registrable Securities that Holders have requested to be included in such registration statement are
actually included. 

  
 12 













 3.4 Obligations of the Company. Whenever required under this
Section 3 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 

(a) prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable
efforts to cause such registration statement to become effective as promptly as practicable, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for a
period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed; provided, however, that (i) such 120-day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of Common Stock (or other securities) of the Company, from selling any
securities included in such registration, and (ii) in the case of any registration of Registrable Securities on Form S-3 that are intended to be offered on a continuous or delayed basis, subject to
compliance with applicable SEC rules, such 120-day period shall be extended, if necessary, to keep the registration statement effective until all such Registrable Securities are sold; 

(b) prepare and file with the SEC such amendments and supplements to such registration statement, the prospectus and, if required, any Free
Writing Prospectus used in connection with such registration statement as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such registration statement; 

(c) furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus and any Free Writing Prospectus,
as required by the Securities Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; 

(d) use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other
securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company shall not be required to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

(e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the underwriter(s) of such offering; 
 (f) use its reasonable efforts to cause all such Registrable Securities covered
by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed; 

(g) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number for
all such Registrable Securities, in each case not later than the effective date of such registration; 
 (h) promptly make available for
inspection by the selling Holders, any managing underwriter(s) participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling
Holders, all financial and other records, pertinent corporate documents, and properties of 

  
 13 













 
the Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney,
accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith; 

(i) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has been
declared effective or a supplement to any prospectus or Free-Writing Prospectus forming a part of such registration statement has been filed; 

(j) after such registration statement becomes effective, notify each selling Holder of any request by the SEC that the Company amend or
supplement such registration statement or prospectus or Free-Writing Prospectus; 
 (k) use its commercially reasonable efforts to obtain
for the underwriters one or more “cold comfort” letters, dated the effective date of the related registration statement (and, if such registration includes an underwritten public offering, dated the date of the closing under the
underwriting agreement), signed by the Company’s independent public accountants in customary form and covering such matters of the type customarily covered by “cold comfort” letters; 

(l) use its commercially reasonable efforts to obtain for the underwriters on the date such securities are delivered to the underwriters for
sale pursuant to such registration a legal opinion of the Company’s outside counsel with respect to the registration statement, each amendment and supplement thereto, the prospectus included therein (including the preliminary prospectus) and
such other documents relating thereto in customary form and covering such matters of the type customarily covered by legal opinions of such nature; 

(m) to the extent the Company is a well-known seasoned issuer (as defined in SEC Rule 405 at the time any request for registration is
submitted to the Company in accordance with Section 3.1, if so requested, file an Automatic Shelf Registration Statement to effect such registration; and 

(n) if at any time when the Company is required to re-evaluate its well-known seasoned issuer status
for purposes of an outstanding Automatic Shelf Registration Statement used to effect a request for registration in accordance with Section 3.1.2 the Company determines that it is not a well-known seasoned issuer and (i) the registration
statement is required to be kept effective in accordance with this Agreement and (ii) the registration rights of the applicable Holders have not terminated, use commercially reasonable efforts to promptly amend the registration statement on a
form the Company is then eligible to use or file a new registration statement on such form, and keep such registration statement effective in accordance with the requirements otherwise applicable under this Agreement. 

3.5 Furnish Information. It shall be a condition precedent to the obligations of the Company to take any
action pursuant to this Section 3 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method
of disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable Securities. 

  
 14 













 3.6 Expenses of Registration. All expenses (other than Selling
Expenses) incurred in connection with registrations, filings, or qualifications pursuant to Section 3, including all registration, filing, and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for
the Company, and the reasonable fees and disbursements of one Selling Holder Counsel, not to exceed $30,000 (unless such counsel is required to deliver any legal opinion(s) in connection therewith), shall be borne and paid by the Company.
Notwithstanding the foregoing, the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 3.1 if the registration request is subsequently withdrawn at the request of the Holders of a
majority of the Registrable Securities to be registered (in which case all selling Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration), unless the Holders
of a majority of the Registrable Securities agree to forfeit their right to one registration pursuant to Section 3.1.1 or Section 3.1.2, as the case may be, during the applicable time period described therein; provided that, if, at
the time of such withdrawal, the Holders shall have learned of a material adverse change in the condition, business, or prospects of the Company not known to the Holders at the time of their request and have withdrawn the request with reasonable
promptness after learning of such information, then the Holders shall not be required to (x) pay any of (and the Company shall pay all) such expenses or (y) forfeit their right to one registration pursuant to Section 3.1.1 or
Section 3.1.2. All Selling Expenses relating to Registrable Securities registered pursuant to this Section 3 shall be borne and paid by the Holders pro rata on the basis of the number of Registrable Securities registered on their behalf.

 3.7 Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining
or otherwise delaying any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 3. 

3.8 Indemnification. If any Registrable Securities are included in a registration statement under this
Section 3: 
 3.8.1 Company Indemnification. To the extent permitted by law, the Company will indemnify and hold harmless each
selling Holder, and the partners, members, officers, directors, and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the Securities Act) for each such Holder; and each Person, if
any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or other aforementioned Person any legal
or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the
indemnity agreement contained in this Section 3.8.1 shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably
withheld, conditioned, or delayed nor shall the Company be liable for any Damages to the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information 

furnished by or on behalf of any such Holder, underwriter, controlling Person, or other aforementioned Person expressly for use in connection with such
registration. 

  
 15 













 3.8.2 Selling Holder Indemnification. To the extent permitted by law, each selling
Holder, severally and not jointly, will indemnify and hold harmless the Company, and each of its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the
Securities Act, legal counsel and accountants for the Company, any underwriter (as defined in the Securities Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other
Holder, against any Damages, in each case only to the extent that such Damages arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder
expressly for use in connection with such registration; and each such selling Holder will pay to the Company and each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending
any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that (a) the indemnity agreement contained in this Section 3.8.2 shall not apply to amounts paid in
settlement of any such claim or proceeding if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld, conditioned or delayed, and (b) that in no event shall the aggregate amounts payable
by any Holder by way of indemnity or contribution under Sections 3.8.2 and 3.8.4 exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of fraud or willful misconduct by
such Holder. 
 3.8.3 Procedures. Promptly after receipt by an indemnified party under this Section 3.8 of notice of the
commencement of any action (including any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this
Section 3.8, give the indemnifying party notice of the commencement thereof. The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly with any other
indemnifying party to which notice has been given, and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other
indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by
the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such action. The failure to give notice to the
indemnifying party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of any liability to the indemnified party under this Section 3.8, solely to the extent that such failure prejudices the
indemnifying party’s ability to defend such action. 
 3.8.4 Contribution. To provide for just and equitable contribution to
joint liability under the Securities Act in any case in which either (a) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Section 3.8 but it is judicially determined (by the entry
of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such 

  
 16 













 
indemnification may not be enforced in such case, notwithstanding the fact that this Section 3.8 provides for indemnification in such case, or (b) contribution under the Securities Act
may be required on the part of any party hereto for which indemnification is provided under this Section 3.8, then, and in each such case, such parties will contribute to the aggregate losses, claims, damages, liabilities, or expenses to which
they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the indemnified party in connection with the statements, omissions, or other actions that
resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among
other things, whether the untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to information supplied by the indemnifying party or by the indemnified party and the parties’
relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; provided, however, that: 

(i) in any such case, (A) no Holder will be required to contribute any amount in excess of the public offering price of all such
Registrable Securities offered and sold by such Holder pursuant to such registration statement, and (B) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to
contribution from any Person who was not guilty of such fraudulent misrepresentation; and 
 (ii) in no event shall a Holder’s
liability pursuant to this Section 3.8.4, when combined with the amounts paid or payable by such Holder pursuant to Section 3.8.2, exceed the proceeds from the offering received by such Holder (net of any Selling Expenses) paid by such
Holder), except in the case of fraud or willful misconduct by such Holder. 
 3.8.5 Underwriting Agreement Controls. Notwithstanding
the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the
provisions in the underwriting agreement shall control. 
 3.8.6 Survival. Unless otherwise superseded by an underwriting agreement
entered into in connection with the underwritten public offering, the obligations of the Company and Holders under this Section 3.8 shall survive the completion of any offering of Registrable Securities in a registration under this
Section 3, and otherwise shall survive the termination of this Agreement. 
 3.9 Reports under the Exchange Act.
With a view to making available to the Holders the benefits of SEC Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant
to a registration on Form S-3, the Company shall: 
 (a) use commercially reasonable efforts to make
and keep available adequate current public information, as those terms are understood and defined in SEC Rule 144, at all times after the effective date of the registration statement filed by the Company for the IPO; 

  
 17 













 (b) use commercially reasonable efforts to file with the SEC in a timely manner all reports
and other documents required of the Company under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements); and 

(c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) to the extent accurate, a
written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the registration statement filed by the Company for the IPO), the Securities Act,
and the Exchange Act (at any time after the Company has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time
after the Company so qualifies); and (ii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration (at any time after
the Company has become subject to the reporting requirements under the Exchange Act) or pursuant to Form S-3 (at any time after the Company so qualifies to use such form). 

3.10 Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company
shall not, without the prior written consent of the Holders of a majority of the Registrable Securities then outstanding, including the KKR Investor for so long as KKR continues to own at least 18,181,818 shares of Series A Preferred Stock, enter
into any agreement with any holder or prospective holder of any securities of the Company that would allow such holder or prospective holder to include such securities in any registration if such agreement (a) would allow such holder or
prospective holder to include a portion of its securities in any “piggyback” registration if such inclusion could reduce the number of Registrable Securities that selling Holders could be entitled to include in such registration under
Sections 3.2 and 3.3.2 hereof or (b) would allow such holder or prospective holder to initiate a demand for registration of any of its securities at a time earlier than the Holders of Registrable Securities can demand registration under
Section 3.1 hereof. This Section 3.10 shall not apply with respect to the grant of “piggyback” registration rights to a holder of a Lender Warrant. 

3.11 “Market Stand-off” Agreement. Each Holder hereby agrees
that, during the Standoff Period, such Holder will not, without the prior written consent of the Company or the managing underwriter, 

(a) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right, or warrant to purchase or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock, or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Common Stock, held
immediately before the effective date of the registration statement for such offering; or 
 (b) enter into any swap or other arrangement
that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause (a) or (b) above is to be settled by delivery of Common Stock or other
securities, in cash, or otherwise. 

  
 18 













 The foregoing provisions of this Section 3.11 shall not apply to the sale of any shares to an
underwriter pursuant to an underwriting agreement, and shall be applicable to the Holders only if all officers, directors, and stockholders individually owning more than two percent (2%) of the Company’s outstanding Common Stock (after giving
effect to conversion into Common Stock of all outstanding Preferred Stock) are similarly bound. For purposes of this Section 3.11, the term “Company” shall include any wholly-owned subsidiary of the Company into which the Company
merges or consolidates. In order to enforce the foregoing covenant, the Company shall have the right to place restrictive legends on the certificates representing the shares subject to this Section 3.11 and to impose stop transfer instructions
with respect to such shares until the end of such period. The underwriters in connection with such registration are intended third-party beneficiaries of this Section 3.11 and shall have the right, power, and authority to enforce the provisions
hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration that are consistent with this Section 3.11 or that are
necessary to give further effect thereto. 
 3.12 Restrictions on Transfer. 

3.12.1 Agreement Binding. The Preferred Stock and the Registrable Securities shall not be sold, pledged, or otherwise transferred, and
the Company shall not recognize and shall issue stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon the conditions specified in this Agreement, which conditions are intended to ensure
compliance with the provisions of the Securities Act. A transferring Holder will cause any proposed purchaser, pledgee, or transferee of the Preferred Stock and the Registrable Securities held by such Holder to agree to take and hold such securities
subject to the provisions and upon the conditions specified in this Agreement. 
 3.12.2 Legends. Each certificate or instrument
representing (a) the Preferred Stock, (b) the Registrable Securities, and (c) any other securities issued in respect of the securities referenced in clauses (a) and (b), upon any stock split, stock dividend, reclassification,
recapitalization, merger, consolidation, or similar event, shall (unless otherwise permitted by the provisions of Section 3.12.3) be stamped or otherwise imprinted with a legend substantially in the following form: 

THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED FOR
INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM REASONABLY SATISFACTORY TO THE
COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. 

  
 19 













 THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE
TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 
 The Holders consent to the
Company making a notation in its records and giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer set forth in this Section 3.12. 

3.12.3 Procedure. The holder of each certificate representing Restricted Securities, by acceptance thereof, agrees to comply in all
respects with the provisions of this Section 3. Before any proposed sale, pledge, or transfer of any Restricted Securities, unless there is in effect a registration statement under the Securities Act covering the proposed transaction, the
Holder thereof shall give notice to the Company of such Holder’s intention to effect such sale, pledge, or transfer. Each such notice shall describe the manner and circumstances of the proposed sale, pledge, or transfer in sufficient detail
and, if reasonably requested by the Company, shall be accompanied at such Holder’s expense by either (a) a written opinion of legal counsel who shall, and whose legal opinion shall, be reasonably satisfactory to the Company, addressed to
the Company, to the effect that the proposed transaction may be effected without registration under the Securities Act; (b) a “no action” letter from the SEC to the effect that the proposed sale, pledge, or transfer of such Restricted
Securities without registration will not result in a recommendation by the staff of the SEC that action be taken with respect thereto; or (c) any other evidence reasonably satisfactory to counsel to the Company to the effect that the proposed sale,
pledge, or transfer of the Restricted Securities may be effected without registration under the Securities Act, whereupon the Holder of such Restricted Securities shall be entitled to sell, pledge, or transfer such Restricted Securities in
accordance with the terms of the notice given by the Holder to the Company. The Company will not require such a legal opinion or “no action” letter (i) in any transaction in compliance with SEC Rule 144 or (ii) in any transaction
in which such Holder distributes Restricted Securities to an Affiliate of such Holder for no consideration; provided that each transferee agrees in writing to be subject to the terms of this Section 3.12. Each certificate or instrument
evidencing the Restricted Securities transferred as above provided shall bear, except if such transfer is made pursuant to SEC Rule 144, the appropriate restrictive legend set forth in Section 3.12.2, except that such certificate shall not bear
such restrictive legend if, in the opinion of counsel for such Holder and the Company, such legend is not required in order to establish compliance with any provisions of the Securities Act. Until the IPO, unless approved by the Board prior to such
Transfer, no Investor shall Transfer any Restricted Securities to any other person or entity (other than its Affiliates); provided, however, that notwithstanding the foregoing, upon the earlier of (a) the four
(4) year anniversary of the Closing (as defined in the Purchase Agreement) and (b) the occurrence of a Fundamental Event, each Investor shall be permitted to Transfer Restricted Securities to another person or entity that is
(i) determined not to be a competitor of the Company, in the good faith judgment of the Board, and (ii) reasonably acceptable to the Board. Any purported Transfer of any Restricted Securities effected in violation of this Section 3
shall be null and void and shall have no force or effect and the Company shall not register any such purported Transfer. 

  
 20 













 4. RIGHTS TO FUTURE STOCK ISSUANCES. Subject to the terms and
conditions of this Section 4 and applicable securities laws, each time the Company proposes to sell any New Securities, the Company shall offer to sell a portion of New Securities to each Major Investor as described in this Section 4.
A Major Investor shall be entitled to apportion the right of first refusal hereby granted to it among itself and its Affiliates in such proportions as it deems appropriate. The right of first refusal in this Section 4 shall not be applicable
with respect to any Major Investor, if at the time of such subsequent securities issuance, the Major Investor is not an “accredited investor,” as that term is then defined in Rule 501(a) under the Securities Act. 

4.1 Company Notice. The Company shall give notice (the “Offer Notice”) to each Major
Investor, stating (a) its bona fide intention to sell such New Securities, (b) the number of such New Securities to be sold and (c) the price and terms, if any, upon which it proposes to sell such New Securities. 

4.2 Investor Right. By written notice (the “Investor Notice”) to the Company within
twenty (20) days after the Offer Notice is given, each Major Investor may elect to purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to such Major Investor’s Pro Rata Amount. In addition, each
Major Investor that elects to purchase or acquire all of its Pro Rata Amount (each, a “ Fully Exercising Investor”) may, in the Investor Notice, elect to purchase or acquire, in addition to its Pro Rata Amount, a portion of
the New Securities, if any, for which other Major Investors were entitled to subscribe but that are not subscribed for by such Major Investors. The amount of such overallotment that each Fully Exercising Investor shall be entitled to purchase is
equal to the proportion that the Common Stock issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of Preferred Stock and any other Derivative Securities then held, by such Fully Exercising Investor
bears to the Common Stock issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of the Preferred Stock and any other Derivative Securities then held, by all Fully Exercising Investors who wish to
purchase such unsubscribed New Securities. A Major Investor’s election may be conditioned on the consummation of the transaction described in the Offer Notice. The closing of any sale pursuant to this Section 4.2 shall occur on the earlier
of one hundred and twenty (120) days after the date that the Offer Notice is given and the date of initial sale of New Securities pursuant to Section 4.3. 

4.3 Sale of Securities. If all New Securities referred to in the Offer Notice are not elected to be
purchased or acquired by the Major Investors as provided in Section 4.2, the Company may, during the ninety (90) day period following the expiration of the periods provided in Section 4.2, offer and sell the remaining unsubscribed
portion of such New Securities to any Person or Persons at a price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New
Securities within such period, or if such agreement is not consummated within thirty (30) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first
reoffered to the Major Investors in accordance with this Section 4. 
 4.4 Alternate Procedure.
Notwithstanding any provision hereof to the contrary, in lieu of complying with the provisions of Sections 4.1 and 4.2, the Company may elect to give notice to the Major Investors within thirty (30) days after the issuance of New
Securities. Such notice shall describe the type, price, and terms of the New Securities, and the identities of the Persons to whom the New Securities were sold. Each Major Investor shall have 

  
 21 













 
twenty (20) days after the date the Company’s notice is given to elect, by giving notice to the Company, to purchase up to the number of New Securities that such Major Investor would
otherwise have the right to purchase pursuant to Section 4.2 above had the Company complied with the provisions of Sections 4.1 and 4.2 in connection with the issuance of such New Securities under the terms and conditions set forth in the
Company’s notice pursuant to this Section 4.4. Any Major Investors electing to purchase such New Securities shall also have rights of oversubscription to purchase New Securities that were purchasable by other Major Investors pursuant to
the foregoing sentence but were not so purchased, and such rights of oversubscription shall be apportioned in a manner consistent with the apportionment among Fully Exercising Investors described in Section 4.2. The closing of such sale shall
occur within sixty (60) days of the date notice is given to the Major Investors. 
 5. ADDITIONAL COVENANTS. 

5.1 Insurance. The Company shall obtain, within ninety (90) days of the date hereof, from financially
sound and reputable insurers Directors and Officers liability insurance in an amount and on terms and conditions satisfactory to the Board (including the KKR Designee, if then in office), and will use commercially reasonable efforts to cause such
insurance policies to be maintained until such time as the Board (including the KKR Designee, if then in office) determines that such insurance should be discontinued. 

5.2 Board Matters . Unless otherwise determined by the vote of a majority of the directors then in office,
the Board shall meet at least quarterly in accordance with an agreed-upon schedule. The Company shall reimburse the nonemployee directors (including the KKR Designee) for all reasonable
out-of-pocket travel expenses incurred (consistent with the Company’s travel policy) in connection with attending meetings of the Board. Each non-employee director designated pursuant to the Voting Agreement shall be entitled in such person’s discretion to be a member of any Board committee or subcommittee. 

5.3 Right to Conduct Activities. The Company hereby agrees and acknowledges that KKR is a professional investment
fund, and as such invests in numerous portfolio companies, some of which may be deemed competitive with the Company’s business (as currently conducted or as currently proposed to be conducted). The Company hereby agrees that, to the extent
permitted under applicable law, KKR shall not be liable to the Company for any claim arising out of, or based upon, (a) the investment by KKR in any entity competitive with the Company, or (b) actions taken by any partner, officer or other
representative KKR to assist any such competitive company, whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and whether or not such action has a detrimental effect on the Company;
provided, however, that the foregoing shall not relieve (x) KKR from liability associated with the unauthorized disclosure of the Company’s confidential information obtained pursuant to this Agreement or otherwise in violation of any
contractual obligation of KKR to the Company, or (y) any director or officer of the Company from any liability associated with his or her fiduciary duties to the Company. 

  
 22 













 5.4 Anti-Corruption and International Risk Compliance. 

5.4.1 The Company and each Investor covenants that they shall not, and shall procure (through the exercise of their votes and any rights
attached to their shares and all other necessary or desirable actions within their control), that neither the Company nor its Subsidiaries, nor any of their respective directors, officers, employees or agents shall: (a) offer, promise, provide,
or authorize the provision of any money, property, contribution, gift, entertainment or other thing of value, directly or indirectly, to any government official (including any officer or employee of a government or government-owned
or—controlled entity or of a public international organization, or any political party or party official or candidate for political office), or any other Person acting in an official capacity, to influence official action or secure an improper
advantage, or to encourage the recipient to breach a duty of good faith or loyalty or the policies of his/her employer, or otherwise in violation of any Anti-Bribery Law; (b) engage in any dealings or transactions with or for the benefit of any
Sanctioned Person, nor otherwise violate Sanctions; (c) violate any Anti-Money Laundering Laws or Export Control Laws; or (d) invest any earnings from criminal activities in the Company or its Subsidiaries. 

5.4.2 No Party to this Agreement is a Sanctioned Person nor is acting for or on behalf of any Sanctioned Person, and the monies used to fund
such Party’s investment in the Company have not been derived from any Sanctioned Person or from activity undertaken in violation of Sanctions, Anti-Bribery Laws, or Anti-Money Laundering Laws. 

5.4.3 As soon as reasonably practicable following the date hereof, the Company shall prepare and implement (or revise, as the case may be)
policies and procedures reasonably designed to prevent, detect and deter violations of Anti-Bribery Laws, Sanctions, Anti-Money Laundering Laws, and Export Control Laws. 

5.4.4 The Company shall promptly notify the Investors of any actual or threatened legal proceedings or enforcement action relating to any
breach or suspected breach of Anti-Bribery Laws, Sanctions, Anti-Money Laundering Laws, or Export Control Laws. 
 5.5 Privacy
and Data Security Matters. 
 5.5.1 The Company will (i) assess the Gaming Subsidiaries’ compliance with applicable
Privacy Legal Requirements that are binding on the Gaming Subsidiaries with respect to products owned or developed by the Gaming Subsidiaries, with such assessment to be commenced and completed as soon as reasonably practicable following the date of
this Agreement; and (ii) as promptly as reasonably practicable thereafter, to the extent not already in place as of the date of this Agreement, make commercially reasonable efforts to put in place a privacy and data protection compliance
program appropriately designed to, at a minimum, (A) ensure the Gaming Subsidiaries’ compliance with all such applicable Privacy Legal Requirements; and (B) evaluate and comply with applicable Privacy Legal Requirements that are
binding on the Gaming Subsidiaries with respect to all products owned or developed by the Gaming Subsidiaries and later acquired Subsidiaries that own or develop software games and mobile app games after the date of this Agreement, and as they may
be enacted or modified over time, including the California Consumer Privacy Act. 
 5.5.2 The Company will, within twelve (12) months
of the date of this Agreement: (i) hire a full-time general counsel, or full-time in-house counsel with responsibility for privacy, data security, and the Company’s and its Subsidiaries’ ongoing
compliance with Privacy Legal Requirements, and will (A) cause such person to, as promptly as reasonably practicable after the date on which such person commences duties for the Company, conduct 

  
 23 













 
(utilizing outside counsel as reasonably appropriate) a complete assessment of the Company’s and its Subsidiaries’ compliance with Privacy Legal Requirements, and (B) use
commercially reasonable efforts to remediate any noncompliance therewith; and (ii) adopt and maintain an ongoing privacy and data security compliance program that includes, without limitation, policies and procedures that are, at minimum,
customary and reasonable for a company in the industry of the Company and its Subsidiaries and with the scope and amount of commercial activities of the Company and its Subsidiaries (which may include, as applicable, existing policies and procedures
of the Company and its Subsidiaries); 
 5.5.3 The Company will assess the Gaming Subsidiaries’ use of and compliance with Open Source
Materials incorporated into the products owned or developed by the Gaming Subsidiaries, with such assessment to be commenced and completed as soon as reasonably practicable following the date of this Agreement; and (ii) as promptly as
reasonably practicable thereafter, to the extent not already in place as of the date of this Agreement, make commercially reasonable efforts to put in place a compliance program appropriately designed to, at a minimum, (A) ensure that the
Gaming Subsidiaries comply with all the terms and conditions of the applicable licenses; (B) ensure that the Gaming Subsidiaries do not use such Open Source Materials in such a way that would obligate the Gaming Subsidiaries under the terms of
such licenses to distribute, license or make available to any third party the source code of any the Gaming Subsidiaries’ products (other than the applicable Open Source Material itself); and (C) ensure the foregoing in (A) and (B)
for any products owned or developed by the Gaming Subsidiaries and later acquired Subsidiaries that own or develop software games and mobile app games after the date of this Agreement. 

5.5.4 The Company will make commercially reasonable efforts to conduct analysis of the software games and mobile apps owned or developed by
the Gaming Subsidiaries to confirm that such products do not infringe a third party’s valid copyright, with such analysis to be commenced and completed as soon as reasonably practicable following the date of this Agreement; and on an ongoing
basis after the date of this Agreement, make commercially reasonable efforts to conduct such analysis for any software games or mobile apps owned or developed by the Gaming Subsidiaries and later acquired Subsidiaries that own or develop software
games and mobile app games after the date of this Agreement. 
 5.5.5 The Company will, within six (6) months of the Closing Date, and
on an ongoing basis, report to the Board with respect to the Company’s and its Subsidiaries’ privacy, data security, and cybersecurity risks and associated strategies, policies, programs, and practices. 

6. TERMINATION. 

6.1 Generally. The covenants set forth in Section 2.1, Section 2.2, Section 2.3,
Section 4 and Section 5 (other than Section 5.3) shall terminate and be of no further force or effect upon the earliest to occur of: (a) immediately before (but subject to) the consummation of a Qualified Public Offering (as
defined in the Restated Certificate); (b) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act; or (c) subject to the terms and conditions set forth in the Restated
Certificate, upon the consummation of a Deemed Liquidation Event or a Stock Sale. 

  
 24 













 6.2 Registration Rights. The right of any Holder to request
registration or inclusion of Registrable Securities in any registration pursuant to Section 3.1 or Section 3.2 shall terminate upon the earliest to occur of: (a) when all of such Holder’s Registrable Securities could be
sold without any restriction on volume or manner of sale in any three-month period under SEC Rule 144 or any successor; and (b) subject to the terms and conditions set forth in the Restated Certificate upon the consummation of a Deemed
Liquidation Event or a Stock Sale. 
 7. GENERAL PROVISIONS. 

7.1 Successors and Assigns. The rights under this Agreement may be assigned (but only with all related
obligations) by a Holder to a transferee of Registrable Securities that (a) is an Affiliate, partner, member, limited partner, retired or former partner, retired or former member, or stockholder of a Holder or such Holder’s Affiliate;
(b) is a Holder’s Immediate Family Member or trust for the benefit of an individual Holder or one or more of such Holder’s Immediate Family Members; (c) after such transfer, holds at least two percent (2%) of the shares of
Registrable Securities (or if the transferring Holder owns less than two percent (2%) of the Registrable Securities, then all Registrable Securities held by the transferring Holder); or (d) is a venture capital fund that is controlled by or
under common control with one or more general partners or managing partners or managing members of, or shares the same management company with, the Holder; provided, however, that (i) the Company is, within a
reasonable time after such transfer, furnished with written notice of the name and address of such transferee and the Registrable Securities with respect to which such rights are being transferred; and (ii) such transferee agrees in a written
instrument delivered to the Company to be bound by and subject to the terms and conditions of this Agreement, including the provisions of Section 3.11. For the purposes of determining the number of shares of Registrable Securities held by a
transferee, the holdings of a transferee (A) that is an Affiliate, limited partner, retired or former partner, member, retired or former member, or stockholder of a Holder or such Holder’s Affiliate; (B) who is a Holder’s
Immediate Family Member; or (C) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family Member shall be aggregated together and with those of the transferring Holder. The terms and conditions of this
Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their
respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided herein. 

7.2 Governing Law. This Agreement and any controversy arising out of or relating to this Agreement shall be
governed by and construed in accordance with the General Corporation Law of the State of Delaware to the extent applicable, and to the extent the General Corporation Law of the State of Delaware is not applicable, the laws of the State of
California, without regard to conflict of law principles that would result in the application of any law other than such laws. 
 7.3
Counterparts; Facsimile. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This
Agreement may also be executed and delivered by facsimile signature and in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

  
 25 













 7.4 Titles and Subtitles. The titles and subtitles used in this
Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. 
 7.5
Notices. All notices, requests, and other communications given, made or delivered pursuant to this Agreement shall be in writing and shall be deemed effectively given, made or delivered upon the earlier of actual
receipt or: (a) personal delivery to the party to be notified; (b) when sent, if sent by facsimile during the recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s next business
day; (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) one (1) business day after the business day of deposit with a nationally recognized overnight courier, freight
prepaid, specifying next-day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their addresses as set forth on Schedule A hereto, or to the principal
office of the Company and to the attention of the Chief Executive Officer, in the case of the Company, or to such address or facsimile number as subsequently modified by written notice given in accordance with this Section 7.5. If notice is
given to the Company, it shall be sent to 849 High Street, Palo Alto, California 94301, marked “Attention: Chief Executive Officer”; and a copy (which shall not constitute notice) shall also be sent to Fenwick & West LLP, Silicon
Valley Center, 801 California Street, Mountain View, California 94041, Attn: Michael Esquivel. If no facsimile number is listed on Schedule A for a party (or above in the case of the Company), notices and communications given or made by
facsimile shall not be deemed effectively given to such party. 
 7.6 Amendments and Waivers. This Agreement may
only be amended or terminated and the observance of any term hereof may be waived (either generally or in a particular instance, and either retroactively or prospectively) only by a written instrument executed by (a) the Company,
(b) for so long as at least 18,181,818 shares of Series A Preferred Stock remain outstanding (as such number is adjusted for stock splits, stock combinations, stock dividends, recapitalizations, reclassifications or the like), the Investors
holding a majority of the shares of Series A Preferred Stock then outstanding (voting as a separate class), and (c) (i) with respect to Sections 2 and 4 and any other provision of this Agreement to the extent such provision pertains to
Section 2 or 4, the holders of a majority of the Registrable Securities then outstanding and held by the Major Investors or (ii) with respect to any other provision of this Agreement, the holders of a majority of the Registrable Securities
then outstanding; provided that (A) the Company may in its sole discretion waive compliance with Section 3.12; (B) any provision hereof may be waived by any waiving party on such party’s own behalf, without the consent of any other
party; and (C) the Company may, without the consent or approval of any other party hereto, cause additional persons to become party to this Agreement as Lenders pursuant to Section 7.14 hereto and amend Schedule A hereto
accordingly. Notwithstanding the foregoing, each of Section 2.3 and this sentence may not be amended, and no provision thereof may be waived, without the written consent of KKR. Further, this Agreement may not be amended, and no provision
hereof may be waived, in each case, in any way which would adversely affect the rights of the Key Holders hereunder in a manner disproportionate to any adverse effect such amendment or waiver would have on the rights of the Investors hereunder,
without also the written consent of the holders of a majority of the Registrable Securities held by the Key Holders; provided, however, that the grant to third parties of piggyback registration rights under
Section 3.2 hereof shall not be deemed to be an adverse change to the piggyback registration rights of the Key Holders under this Agreement and shall not require the consent of 

  
 26 













 
the Key Holders. Further, this Agreement may not be amended, modified or terminated and the observance of any term hereunder may not be waived with respect to an Investor without the written
consent of such Investor, if such amendment, modification, termination or waiver would materially increase the obligations of, or impose any new affirmative obligation on, such Investor or adversely affect such Investor in a manner different or
disproportionate than the effect that such amendment, modification, termination or waiver would have on the other Investors or the Key Holders under this Agreement; provided that the addition of new Investors to this Agreement holding rights senior
to or pari passu with the rights of such Investor shall not in and of itself constitute such a material increase or disproportionate adverse effect. Any amendment, termination, or waiver effected in accordance with this Section 7.6 shall be
binding on each party hereto and all of such party’s successors and permitted assigns, regardless of whether or not any such party, successor or assignee entered into or approved such amendment, termination, or waiver. No waivers of or
exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision. 

7.7 Severability. In case any one or more of the provisions contained in this Agreement is for any reason
held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be reformed and
construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law. 
 7.8 Aggregation of
Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement and such affiliated persons may
apportion such rights as among themselves in any manner they deem appropriate. 
 7.9 Entire Agreement. This
Agreement (including any Schedules and Exhibits hereto) constitutes the full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject
matter hereof existing between the parties is expressly canceled and replaced with this Agreement. 
 7.10 Third
Parties. Nothing in this Agreement, express or implied, is intended to confer upon any person, other than the parties hereto and their successors and assigns, any rights or remedies under or by reason of this Agreement. 

7.11 Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party
under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or acquiescence to any
such breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All remedies, whether under
this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative. 

  
 27 













 7.12 Dispute Resolution. The parties (a) hereby irrevocably
and unconditionally submit to the jurisdiction of the federal or state courts located in the Northern District of California for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree
not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the federal or state courts located in the Northern District of California, and (c) hereby waive, and agree not to assert, by way of
motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that a party is not subject to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution based upon judgment
or order of such court(s), that any suit, action or proceeding arising out of or based upon this Agreement commenced in the federal or state courts located in the Northern District of California is brought in an inconvenient forum, that the venue of
such suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court. Should any party commence a suit, action or other proceeding arising out of or based upon this Agreement in a
forum other than the federal or state courts located in the Northern District of California, or should any party otherwise seek to transfer or dismiss such suit, action or proceeding from such court(s), that party shall indemnify and reimburse the
other party for all legal costs and expenses incurred in enforcing this provision. 
 7.13 Attorneys’ Fees.
If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the non-prevailing party shall pay all costs and expenses incurred by the prevailing party,
including, without limitation, all reasonable attorneys’ fees. 
 7.14 Additional Lenders. Notwithstanding
anything to the contrary contained herein, if the Company issues any Lender Warrant, any recipient of a Lender Warrant may become a party to this Agreement by executing and delivering an additional counterpart signature page to this
Agreement, and thereafter shall be deemed a “Lender” for all purposes hereunder. No action or consent by the Investors shall be required for such joinder to this Agreement by such additional or Lender, so long as such additional Lender has
agreed in writing to be bound by all of the obligations as a “Lender” hereunder. 
 7.15
Class F Common Stock . For so long as KKR continues to own at least 18,181,818 shares of Series A Preferred Stock, the Company shall not, without the prior written consent of KKR,
issue or sell (or authorize or approve the issuance or sale of) any additional shares of Class F Common Stock, or any securities or rights convertible into or exchangeable for shares of Class F Common Stock. 

[SIGNATURE PAGES FOLLOW] 

  
 28 













 IN WITNESS WHEREOF, the parties hereto have executed this Investors’ Rights
Agreement as of the date first written above. 
 COMPANY: 
  

			
	APPLOVIN CORPORATION
		
	By:	 	 /s/ Adam Foroughi

	Name:	 	Adam Foroughi
	Title:	 	Chief Executive Officer

 [SIGNATURE PAGE TO APPLOVIN CORPORATION
INVESTORS’ RIGHTS AGREEMENT] 












 IN WITNESS WHEREOF, the parties hereto have executed this Investors’ Rights
Agreement as of the date first written above. 
 INVESTORS: 
  

			
	APPLOVIN HOLDINGS LLC 
		
	By:	 	 /s/ Yuntao MA

	Name:	 	Yuntao MA
	Title:	 	Director

 [SIGNATURE PAGE TO APPLOVIN CORPORATION
INVESTORS’ RIGHTS AGREEMENT] 
  












 IN WITNESS WHEREOF, the parties hereto have executed this Investors’ Rights
Agreement as of the date first written above. 
 INVESTORS: 
  

			
	KKR DENALI HOLDINGS, L.P.
	
	By: KKR Denali Holdings GP LLC
	Its: General Partner
		
	By:	 	 /s/ Herald Chen

	Name:	 	Herald Chen
	Title:	 	President

 [SIGNATURE PAGE TO APPLOVIN CORPORATION
INVESTORS’ RIGHTS AGREEMENT] 
  












 IN WITNESS WHEREOF, the parties hereto have executed this Investors’ Rights
Agreement as of the date first written above. 
 KEY HOLDERS: 

 

			
		
	Signature:	 	/s/ Adam Foroughi
		 	Adam Foroughi

  

			
	THE FOROUGHI 2015 IRREVOCABLE TRUST


			
		
	By:	 	/s/ Adam Foroughi


			
	Name:	 	Adam Foroughi
	Title:	 	Trustee

  

			
	Signature:	 	 /s/ Andrew Karam

		 	Andrew Karam

  

			
	THE KARAM 2015 IRREVOCABLE TRUST


			
		
	By:	 	/s/ Andrew Karam


			
	Name:	 	Andrew Karam
	Title:	 	Trustee

  

			
		
	Signature:	 	/s/ John Krystynak
		 	John Krystynak

  

			
	THE JOHN KRYSTYNAK 2018 ANNUITY TRUST


			
		
	By:	 	/s/ John Krystynak


			
	Name:	 	John Krystynak
	Title:	 	Trustee

 [SIGNATURE PAGE TO APPLOVIN CORPORATION
INVESTORS’ RIGHTS AGREEMENT] 












 SCHEDULE A 

List of Investors 
  

	
	Name and Address of Investor
	
	 KKR Denali Holdings, L.P.
 Kohlberg Kravis
Roberts & Co.
 9 West 57th Street, Suite 4200

New York, New York 10022

	
	 AppLovin Holdings LLC
 701 North Block C, Raycom
Infotech Park
 No.2 Kexueyuan South Road, Beijing


  












 SCHEDULE B 

List of Key Holders 
  

	
	Name and Address of Key Holder 
	
	 Adam Foroughi
 [***]

	
	 The Foroughi 2015 Irrevocable Trust

[***]

	
	 Andrew Karam
 [***]

	
	 The Karam 2015 Irrevocable Trust

[***]

	
	 John Krystynak
 [***]

	
	 John Krystynak, Trustee of The John Krystynak 2018 Annuity Trust

[***]














 AMENDMENT NO. 1 TO 

INVESTORS’ RIGHTS AGREEMENT 

This Amendment No. 1 to Investors’ Rights Agreement (this “Amendment”) is made as of March 16, 2021 by
and among Applovin Corporation, a Delaware corporation (the “Company”), and certain of the parties listed as “Investors” (each hereinafter individually referred to as a “Investor” and
collectively referred to as the “Investors”) on Schedule A to that certain Investors’ Rights Agreement dated as of August 15, 2018 by and among the Company, the Investors and the Key Holders (as defined therein)
(the “Rights Agreement”). Capitalized terms not herein defined shall have the meanings ascribed to them in the Rights Agreement. 

RECITALS 
 WHEREAS,
pursuant to Section 7.6 of the Rights Agreement, the Rights Agreement may be amended by a written instrument executed by (a) the Company, (b) for so long as at least 54,545,454 shares of Series A Preferred Stock (which number of
shares reflects a 1-to-3 forward stock split of all of the Company’s shares of capital stock effected on May 20, 2020) remain outstanding (as such number is
adjusted for stock splits, stock combinations, stock dividends, recapitalizations, reclassifications or the like), the Investors holding a majority of the shares of Series A Preferred Stock then outstanding (voting as a separate class), and
(c) (i) with respect to Sections 2 and 4 and any other provision of this Agreement to the extent such provision pertains to Section 2 or 4, the holders of a majority of the Registrable Securities then outstanding and held by the Major
Investors or (ii) with respect to any other provision of this Agreement, the holders of a majority of the Registrable Securities then outstanding (collectively, the “Requisite Majority”), and the undersigned Investors
comprise the Requisite Majority. 
 WHEREAS, the Company and the Investors wish to amend the Rights Agreement as set forth herein. 

NOW, THEREFORE, the parties hereby agree as follows: 

1. Amendments. 

1.1 Section 1. The following definition of “Registrable Securities” in
Section 1 of the Rights Agreement shall be amended and restated in its entirety as follows: 
 ““Registrable
Securities” means (a) Common Stock issued or issuable upon conversion of the Preferred Stock; (b) any Common Stock, or any Common Stock issued or issuable upon conversion of other Derivative Securities, held by an Investor (or
its Affiliates); (c) the Key Holder Registrable Securities, provided, however, that such Key Holder Registrable Securities shall not be deemed Registrable Securities and the Key Holders shall not be deemed Holders for the
purposes of Sections 2.1, 2.2, 3.10 and 4; (d) the Lender Registrable Securities, provided, however, that such Lender Registrable Securities shall not be deemed Registrable Securities and the Lenders shall not be
deemed Holders for the purposes of Sections 2.1, 2.2, 3.1, 3.10, 4 and 7.6; (e) the Common Stock issued to the shareholders set forth on Exhibit A of that certain Amended and Restated Share Purchase Agreement, dated as of March 12, 2021 (as may
be amended from time to time, the “Share Purchase Agreement”) pursuant to the Share Purchase Agreement (the “Acquisition Shares” and such holders of Acquisition Shares, the “Acquisition
Shareholders”), provided, however, that such Acquisition Shares shall not be deemed Registrable Securities and the Acquisition Shareholders shall not be deemed Holders for the purposes of Sections 2.1,
2.2, 3.10 and 4; and (f) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other 












 
distribution with respect to, or in exchange for or in replacement of, the shares referenced in clauses (a) through (e) above; excluding in all cases, however, any Registrable Securities
sold by a Person in a transaction in which the applicable rights under this Agreement are not assigned pursuant to Section 7.1, and excluding for purposes of Section 3 any shares for which registration rights have terminated pursuant to
Section 6.2 of this Agreement. Notwithstanding the foregoing, the Company shall in no event be obligated to register any Preferred Stock of the Company, and Holders of Registrable Securities will not be required to convert their Preferred Stock
into Common Stock in order to exercise the registration rights granted hereunder, until immediately before (and subject to the consummation of) the closing of the offering to which the registration relates.” 

1.2 Section 7.6. The following Section 7.6 of the Rights Agreement shall be amended
and restated in its entirety as follows: 
 “7.6 Amendments and Waivers. This Agreement may only be amended or
terminated and the observance of any term hereof may be waived (either generally or in a particular instance, and either retroactively or prospectively) only by a written instrument executed by (a) the Company, (b) for so long as at least
54,545,454 shares of Series A Preferred Stock (which number of shares reflects a 1-to-3 forward stock split of all of the Company’s shares of capital stock effected
on May 20, 2020) remain outstanding (as such number is adjusted for stock splits, stock combinations, stock dividends, recapitalizations, reclassifications or the like), the Investors holding a majority of the shares of Series A Preferred Stock
then outstanding (voting as a separate class), and (c) (i) with respect to Sections 2 and 4 and any other provision of this Agreement to the extent such provision pertains to Section 2 or 4, the holders of a majority of the Registrable
Securities then outstanding and held by the Major Investors or (ii) with respect to any other provision of this Agreement, the holders of a majority of the Registrable Securities then outstanding; provided that (A) the Company may in its
sole discretion waive compliance with Section 3.12; (B) any provision hereof may be waived by any waiving party on such party’s own behalf, without the consent of any other party; and (C) the Company may, without the consent or
approval of any other party hereto, cause additional persons to become party to this Agreement as Lenders pursuant to Section 7.14 hereto and amend Schedule A hereto accordingly. Notwithstanding the foregoing, each of Section 2.3 and this
sentence may not be amended, and no provision thereof may be waived, without the written consent of KKR. Further, this Agreement may not be amended, and no provision hereof may be waived, in each case, in any way which would adversely affect the
rights of the Key Holders hereunder in a manner disproportionate to any adverse effect such amendment or waiver would have on the rights of the Investors hereunder, without also the written consent of the holders of a majority of the Registrable
Securities held by the Key Holders; provided, however, that the grant to third parties of piggyback registration rights under Section 3.2 hereof shall not be deemed to be an adverse change to the piggyback registration rights of the Key Holders
under this Agreement and shall not require the consent of the Key Holders. Further, this Agreement may not be amended, modified or terminated and the observance of any term hereunder may not be waived with respect to an Investor or the Acquisition
Shareholders without the written consent of such Investor or Acquisition Shareholders holding at least 60% of the shares of Acquisition Shares then outstanding (as applicable), if such amendment, modification, termination or waiver would materially
increase the obligations of, or impose any new affirmative obligation on, such Investor or the Acquisition Shareholders (as applicable), would materially limit, decrease or terminate the rights of such Investor or the Acquisition Shareholders (as
applicable), or otherwise adversely affect such Investor or the Acquisition Shareholders (as applicable), in each case in a manner different or disproportionate than the effect that such amendment, modification, termination or waiver would have on
the other Investors, Acquisition Shareholders or the Key Holders under 

  
 2 













 
this Agreement; provided that the addition of new parties to this Agreement holding rights senior to or pari passu with the rights of such Investor or the Acquisition Shareholders (as applicable)
shall not in and of itself constitute such a material increase or disproportionate adverse effect. Any amendment, termination, or waiver effected in accordance with this Section 7.6 shall be binding on each party hereto and all of such
party’s successors and permitted assigns, regardless of whether or not any such party, successor or assignee entered into or approved such amendment, termination, or waiver. No waivers of or exceptions to any term, condition, or provision of
this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.” 

1.3 Section 7.16. The following shall be added as Section 7.16 to the Rights
Agreement: 
 “7.16 Additional Investors. Notwithstanding anything to the contrary contained herein, if the Company
issues any Acquisition Shares pursuant to the Share Purchase Agreement, any recipient of Acquisition Shares may become a party to this Agreement by executing and delivering an additional counterpart signature page to this Agreement, and thereafter
shall be deemed an “Investor” for all purposes hereunder. No action or consent by the Investors shall be required for such joinder to this Agreement by such additional Investor, so long as such additional Investor has agreed in writing to
be bound by all of the obligations as an “Investor” hereunder.” 
 2. Full Force and Effect.
Except as expressly modified by this Amendment, the terms of the Rights Agreement shall remain in full force and effect. 
 3.
Reference to and effect on the Rights Agreement. Except as expressly modified by this Amendment, all terms of the Rights Agreement shall remain in full force and effect, unmodified in any way. This Amendment shall be deemed
to form an integral part of the Rights Agreement and shall be effective as of date of Rights Agreement as if the provisions hereof had been incorporated into the Rights Agreement as originally executed. 

4. Governing Law. This Amendment and any controversy arising out of or relating to this Agreement shall be governed
by and construed in accordance with the internal law of the State of Delaware, without regard to conflict of law principles. 
 5.
Integration. This Amendment and the Rights Agreement, and the documents referred to herein and therein and the exhibits and schedules thereto, constitute the entire agreement among the parties hereto pertaining to the
subject matter hereof, and any and all other written or oral agreements relating to the subject matter hereof existing between the parties hereto are expressly canceled. 

6. Counterparts; Electronic Signatures. This Agreement may be executed in two or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of
2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

[Signature Pages Follow] 

  
 3 













 In Witness Whereof, the parties hereto have executed this Amendment No. 1 to
Investors’ Rights Agreement as of the date first written above. 
  

			
	COMPANY:
	
	APPLOVIN CORPORATION
		
	By: 	 	 /s/ Adam Foroughi

	Name:	 	Adam Foroughi
	Title:	 	Chief Executive Officer


 [SIGNATURE PAGE TO AMENDMENT
NO. 1 TO INVESTORS’ RIGHTS AGREEMENT] 












 In Witness Whereof, the parties hereto have executed this Amendment No. 1 to
Investors’ Rights Agreement as of the date first written above. 
  

			
	
	INVESTORS: 
	
	KKR DENALI HOLDINGS, L.P.
	
	By: KKR Denali Holdings GP LLC
	Its General Partner
		
	By:	 	 /s/ Ted Oberwager

	Name: Ted Oberwager
	Title: Vice President

 [SIGNATURE PAGE TO AMENDMENT
NO. 1 TO INVESTORS’ RIGHTS AGREEMENT]